Memorial Sloan Kettering Cancer Center in New York has featured this reference to Vitamin D3 research in the “News and Alerts” section of its Integrative Medicine web resource:
Lowered Risk of Cancer with Vitamin D and Calcium Supplementation
June 18, 2007
Conclusions from a double-blind, placebo-controlled trial of 1180 postmenopausal women indicate that supplementation with vitamin D and calcium greatly reduced the risk of cancer. The risk was substantially lowered in women in the vitamin D and calcium group compared to those in calcium alone or placebo groups.
See Memorial Sloan Kettering Cancer Center Guide to Herbs, Botanicals and Other Products for more details.
See also NYBC’s Vitamin D3 product description for more information on recent research on Vitamin D.
NOTE: NYBC also offers a Calcium and Vitamin D3 supplement (Jarrow’s Bone-Up) which allows for a close match of the dosages used in the study described above (1400-1500 mg calcium plus 1100 IU vitamin D3 daily).